Testosterone, the principal androgen in males, is synthesized primarily in the Leydig (interstitial) cells of the testes.
Biosynthetic Pathway
- Cholesterol → (STAR protein) → inner mitochondrial membrane.
- CYP11A1 (side‑chain cleavage) → pregnenolone.
- CYP17A1 (17α‑hydroxylase/17,20‑lyase) → DHEA → androstenedione.
- 17β‑HSD → testosterone.
Regulation (HPG Axis)
- Hypothalamus: GnRH pulse generator.
- Anterior pituitary: LH (stimulates Leydig cells) + FSH (supports Sertoli cells/spermatogenesis).
- Negative feedback: Testosterone (and estradiol via aromatization) inhibits GnRH/LH.
- Inhibin B (from Sertoli cells) selectively inhibits FSH.
Additional Sources
- Adrenal cortex (zona reticularis): DHEA, androstenedione (minor contribution; significant in females, adrenal pathology).
- Peripheral conversion: Androstenedione → testosterone in skin, liver, fat.
Clinical Correlates
- Primary hypogonadism: ↑ LH, ↓ T (testicular failure).
- Secondary hypogonadism: ↓/normal LH, ↓ T (pituitary/hypothalamic).
- Age‑related decline: ~1%/year after 30–40; not universal.
Leydig cells are the engine of male androgen production, tightly governed by the HPG axis.